Naphthoquinone Derivatives Exert Their Antitrypanosomal Activity via a Multi-Target Mechanism
暂无分享,去创建一个
Barbara M. Bakker | Maria Laura Bolognesi | Andrea Cavalli | Federica Prati | Giovanni Capranico | Romana Fato | Christian Bergamini | Leonardo Scapozza | A. Cavalli | M. Bolognesi | L. Scapozza | G. Capranico | R. Perozzo | P. Michels | J. Haanstra | G. Lenaz | R. Brun | F. Prati | Reto Brun | Remo Perozzo | M. Mazet | Giorgio Lenaz | Muriel Mazet | C. Bergamini | R. Fato | Paul A. M. Michels | Jurgen R. Haanstra | Simone Pieretti | S. Pieretti | Federica Prati
[1] C. Clayton,et al. Vectors for inducible expression of toxic gene products in bloodstream and procyclic Trypanosoma brucei. , 1997, Molecular and biochemical parasitology.
[2] Jan-Hendrik S. Hofmeyr,et al. Modelling cellular systems with PySCeS , 2005, Bioinform..
[3] L. Scapozza,et al. Adenosine Kinase of T. b. rhodesiense Identified as the Putative Target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine Using Chemical Proteomics , 2009, PLoS neglected tropical diseases.
[4] D. Durrheim,et al. Current Concepts Control of Neglected Tropical Diseases , 2007 .
[5] Robert A. Copeland,et al. Evaluation of enzyme inhibitors in drug discovery , 2013 .
[6] J. Garbarino,et al. Effects and mode of action of 1,4-naphthoquinones isolated from Calceolaria sessilis on tumoral cells and Trypanosoma parasites. , 1995, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.
[7] A. Cavalli,et al. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates. , 2010, FEMS immunology and medical microbiology.
[8] G. Folkers,et al. A spectrophotometric assay for quantitative determination of kcat of herpes simplex virus type 1 thymidine kinase substrates. , 2001, Analytical biochemistry.
[9] R. Kaminsky,et al. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. , 1997, Acta tropica.
[10] Adam R Renslo,et al. Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.
[11] Robert A Copeland,et al. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. , 2005, Methods of biochemical analysis.
[12] T. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[13] Solomon Nwaka,et al. Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.
[14] V. Hannaert,et al. Glycosomal glyceraldehyde-3-phosphate dehydrogenase of Trypanosoma brucei and Trypanosoma cruzi: expression in Escherichia coli, purification, and characterization of the enzymes. , 1995, Protein expression and purification.
[15] G. Terstappen,et al. Target deconvolution strategies in drug discovery , 2007, Nature Reviews Drug Discovery.
[16] A. Chan,et al. The molecular mechanisms involved in the cytotoxicity of alkannin derivatives. , 2005, European journal of medicinal chemistry.
[17] F. Opperdoes,et al. Glycerol kinase of Trypanosoma brucei. Cloning, molecular characterization and mutagenesis. , 2000, European journal of biochemistry.
[18] Barbara M. Bakker,et al. Experimental and in Silico Analyses of Glycolytic Flux Control in Bloodstream Form Trypanosoma brucei* , 2005, Journal of Biological Chemistry.
[19] Gavin Yamey,et al. The world's most neglected diseases , 2002, BMJ : British Medical Journal.
[20] B. Nare,et al. 2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach , 2011, PLoS neglected tropical diseases.
[21] '. FREDM.D.VELLIEUXa,et al. Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Fèvre,et al. The Burden of Human African Trypanosomiasis , 2008, PLoS neglected tropical diseases.
[23] R. Tapia,et al. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease. , 2011, Current medicinal chemistry.
[24] Multi-target-directed ligands as innovative tools to combat trypanosomatid diseases. , 2011, Current topics in medicinal chemistry.
[25] Michael P Barrett,et al. The trypanosomiases , 2003, The Lancet.
[26] G. Lenaz,et al. Mitochondrial production of reactive oxygen species: Role of Complex I and quinone analogues , 2008, BioFactors.
[27] Ian H Gilbert,et al. Finding new hits in neglected disease projects: target or phenotypic based screening? , 2011, Current topics in medicinal chemistry.
[28] R. Tarleton,et al. Oral Exposure to Trypanosoma cruzi Elicits a Systemic CD8+ T Cell Response and Protection against Heterotopic Challenge , 2011, Infection and Immunity.
[29] S. Croft,et al. Natural products as antiparasitic drugs , 2003, Parasitology Research.
[30] E. Tisdale,et al. Glyceraldehyde-3-phosphate Dehydrogenase Interacts with Rab2 and Plays an Essential Role in Endoplasmic Reticulum to Golgi Transport Exclusive of Its Glycolytic Activity* , 2004, Journal of Biological Chemistry.
[31] Shin-ichi Sato,et al. Biochemical target isolation for novices: affinity-based strategies. , 2010, Chemistry & biology.
[32] Z. Lun,et al. Drug sensitivity of Chinese Trypanosoma evansi and Trypanosoma equiperdum isolates. , 1994, Veterinary parasitology.
[33] Barbara M. Bakker,et al. A domino effect in drug action: from metabolic assault towards parasite differentiation , 2011, Molecular microbiology.
[34] C L Verlinde,et al. Glycolysis as a target for the design of new anti-trypanosome drugs. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[35] Salah Ghabri,et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial , 2009, The Lancet.
[36] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[37] P. Michels,et al. Glucose-6-phosphate dehydrogenase is the target for the trypanocidal action of human steroids. , 2011, Molecular and biochemical parasitology.
[38] Robert B. Raffa,et al. DRUG-RECEPTOR THERMODYNAMICS : introduction and applications , 2001 .
[39] A. Cavalli,et al. Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity. , 2008, Bioorganic & medicinal chemistry letters.
[40] J. Turrens. Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa. , 2004, Molecular aspects of medicine.
[41] R. Brun,et al. Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. , 1979, Acta tropica.
[42] T. Terada,et al. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins. , 2004, Bioorganic & medicinal chemistry.
[43] P. Michels,et al. Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. , 2009, Bioorganic & medicinal chemistry.
[44] R. Nilakantan,et al. 2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2. , 2005, Journal of medicinal chemistry.
[45] Maria Laura Bolognesi,et al. Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania. , 2009, Journal of medicinal chemistry.
[46] M. Wink. Ecological Roles of Alkaloids , 2007 .
[47] Michael P Barrett,et al. Proline Metabolism in Procyclic Trypanosoma brucei Is Down-regulated in the Presence of Glucose* , 2005, Journal of Biological Chemistry.
[48] R. Pink,et al. Opportunities and Challenges in Antiparasitic Drug Discovery , 2005, Nature Reviews Drug Discovery.
[49] R. Perozzo,et al. Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[50] Robert A. Copeland,et al. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis , 1996 .
[51] R. Docampo,et al. Superoxide anion production and trypanocidal action of naphthoquinones on Trypanosoma cruzi. , 1978, Comparative biochemistry and physiology. C: Comparative pharmacology.
[52] T. Halgren,et al. Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules , 1996 .
[53] R Abagyan,et al. Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.
[54] Ram Samudrala,et al. Identification of potential multitarget antimalarial drugs. , 2005, JAMA.
[55] R. Olsen,et al. Identification of Direct Protein Targets of Small Molecules , 2010, ACS chemical biology.
[56] H. Scheraga,et al. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides , 1994 .
[57] Renata L. S. Goncalves,et al. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction. , 2009, Free radical biology & medicine.
[58] Solange Lisboa de Castro,et al. The Trypanocidal Activity of Naphthoquinones: A Review , 2009, Molecules.
[59] Matthew Bogyo,et al. Chemical proteomics and its application to drug discovery. , 2003, Current opinion in biotechnology.
[60] Simon Croft,et al. Kinetoplastids: related protozoan pathogens, different diseases. , 2008, The Journal of clinical investigation.
[61] L. Meijer,et al. Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography , 2007, Biotechnology journal.
[62] C. de Duve. Principles of tissue fractionation. , 1964, Journal of theoretical biology.
[63] M. E. González-Rosende,et al. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives. , 2012, Current medicinal chemistry.
[64] G M Cohen,et al. Quinone chemistry and toxicity. , 1992, Toxicology and applied pharmacology.